$0.237
-0.004 (-1.62%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
KAPA Prediction & Forecast by Similar Chart Analysis
Alphio's KAPA stock price prediction model matches the current Kairos Pharma Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.23 (-1.12%). The 1-week path is $0.23 (-1.57%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Kairos Pharma Ltd Stock?
Kairos Pharma Ltd (KAPA) is not a good buy right now. The stock has seen a staggering year-to-date decline of 67.49% and a one-year change of 83.18%. Additionally, the current RSI of 26.144 indicates that the stock is oversold, but this does not guarantee a rebound. The forward P/E ratio is 0, reflecting a lack of profitability expectations, and the company has reported consistent net losses, with a net income of -1,654,000 USD in Q1 2026. The primary risk is the significant drop in stock price, which has decreased by 18.24% over the last five days, indicating ongoing bearish sentiment.
KAPA stock price ended at $0.24 on Friday, after losing -1.62%
Kairos Pharma Ltd (KAPA) last closed at $0.2371, losing -1.62%. These facts feed the 1-day and 1-week KAPA price prediction above.
Forecast Drivers
Kairos Pharma Ltd (KAPA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches KAPA, ranked by similarity.
Seasonality analysis for KAPA
Historically the probability of a positive August return for KAPA is 0.00%. January offers the highest probability of a positive month at 55.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for KAPA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.10 | $1.15 | $1.27 | +384.22% |
| Sep 2026 | $1.00 | $1.12 | $1.30 | +373.01% |
| Oct 2026 | $0.95 | $1.09 | $1.26 | +359.54% |
| Nov 2026 | $0.84 | $0.96 | $1.13 | +306.54% |
| Dec 2026 | $0.96 | $0.96 | $0.98 | +306.54% |
In 2026, Kairos Pharma Ltd (KAPA) is projected to range from $0.84 to $1.30.
Kairos Pharma Ltd 2026 monthly forecast
In Aug 2026, Kairos Pharma Ltd is projected to average $1.15, with a low of $1.10 and high of $1.27.
In Sep 2026, Kairos Pharma Ltd is projected to average $1.12, with a low of $1.00 and high of $1.30.
In Oct 2026, Kairos Pharma Ltd is projected to average $1.09, with a low of $0.95 and high of $1.26.
In Nov 2026, Kairos Pharma Ltd is projected to average $0.96, with a low of $0.84 and high of $1.13.
In Dec 2026, Kairos Pharma Ltd is projected to average $0.96, with a low of $0.96 and high of $0.98.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.